Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-03-05 @ 1:33 AM
Study NCT ID:
NCT01477918
Status:
UNKNOWN
Last Update Posted:
2011-11-23
First Post:
2011-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
Sponsor:
Asan Medical Center
Organization:
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2011-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.
Primary objective:
• To investigate the prevalence of the MetS in Korean patients with schizophrenia
Secondary objectives:
• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)
Primary objective:
• To investigate the prevalence of the MetS in Korean patients with schizophrenia
Secondary objectives:
• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: